R Squared’s Zenas BioPharma ZBIO Stock Holding History

R Squared’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-210	Closed	-$1.72K	–	1579
2024 Q4	$1.72K	Buy	+210	New	+$3.28K	﹤0.01%	1477

Other funds holding ZBIO

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

R Squared's ZBIO Position: Q1 2025 in Review

R Squared sold out of Zenas BioPharma (ZBIO) in Q1 2025, closing a stake of 210 shares — an estimated $1.72K sold.

R Squared first reported a position in ZBIO in Q4 2024 and held it in 1 quarter. The position peaked at $1.72K in Q4 2024. 67 funds tracked by Wall St. Rank hold ZBIO as of Q1 2025.

R Squared reported no remaining Zenas BioPharma position as of Q1 2025 after selling out during the quarter.
R Squared sold 210 Zenas BioPharma shares in Q1 2025, an estimated $1.72K.
R Squared first reported a position in Zenas BioPharma in Q4 2024 and held it in 1 quarter.
R Squared's Zenas BioPharma position peaked at $1.72K in Q4 2024.
67 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.